Martine Rothblatt: Growing Unlimited Organs, AI Consciousness, & Digital Personhood by 2030 | EP#290
In a Nutshell
Martine Rothblatt's core message is that unlimited healthy lifespan and digital consciousness will both arrive by the 2030s. She is banking on thymus rejuvenation to hit longevity escape velocity, while her Marvatar and other AI work already demonstrate machine consciousness and will soon establish legal personhood for digital minds. The practical takeaway is to pursue only technologies that can scale to billions of people and to accept 95 % solutions now rather than waiting for perfect ones later.
These notes were generated by AI and may contain inaccuracies.
When asked about achieving longevity escape velocity, Rothblatt described it as a tough question because it represents one of the most extraordinary claims in medicine. She referenced the principle that extraordinary claims require extraordinary evidence. While she believes in the possibility of adding 30 extra healthy years to life and supports the mantra of restore, replace, renew at United Therapeutics, she noted that pinning LEV to a specific year exceeds her risk profile. Rothblatt mentioned Ray Kurzweil's prediction of LEV in the early 2030s, while Peter's mantra targets 2033.
Rothblatt identified her current thymus project as the most practical pathway to achieving longevity escape velocity. She explained that the thymus is highly correlated with every key marker of aging due to T-cell receptor diversity. The thymus involutes and gets replaced by fat at age two, becoming dysfunctional by the 20s. This leads to failure in recognizing cancers, increased opportunistic infections, poor vaccine response, and overall frailty in older age.
Rothblatt stated that she believes we are already at the point of AI consciousness and that current models will achieve digital consciousness. She described this as a moment when everything is bursting into a big bang of consciousness.
Rothblatt outlined a three-check decision framework for pursuing ambitious projects: whether she can successfully achieve it, whether she can be the best at it, and whether it will have a big positive impact on the world. She emphasized that entrepreneurs do not need to be experts initially but should talk to experts in the field. She cited George Church as an example, who validated her lung manufacturing approach despite being a wise and old expert.
Rothblatt stressed focusing on technologies that can scale to billions of people. She distinguished between successful companies and world-changing ones, noting that only technologies affecting billions of people truly change the world. She referenced Peter's XPRIZE work as an example that scaled to affect millions and then billions of people.
Rothblatt described viewing each "no" as a way to become smarter. She maintains openness to criticism, considering critics as best friends who help improve success. She evaluates whether criticism has merit without taking it personally. If criticism has no merit, she registers it as situational awareness. If it identifies missing enabling technologies, she investigates those technologies.
Rothblatt advised entrepreneurs to first ensure competency to succeed in an area. Second, focus on creating the best product rather than being a me-too competitor. She emphasized that there is always room at the top, and being a me-too product leads to business failure.
Rothblatt detailed four thymus programs at United Therapeutics:
- Partnerships with Arizona State University (Professor Nancy Manley) and University of British Columbia (Professor Peter Zantra) to manufacture thymuses outside the body for implantation
- Allogeneic thymus program using non-patient DNA, arguing the thymus teaches the body to accept non-self DNA as self
- Autologous thymus program using patient stem cells to create DNA-matched thymuses
- Xenothymus program using genetically modified pig thymus, already FDA-approved for kidney transplant trials
- Thymune acquisition from George Church, focusing on thymic progenitor cell boosters that create ectopic thymuses
One program is already in human clinical trials - the thymo-kidney transplant program. Rothblatt estimated these interventions could be available in the 2030s.
Rothblatt provided updates on other organ programs:
- Kidney xenotransplant clinical trials ongoing, with manufacturing facilities in Christiansburg Virginia, Rochester Minnesota (August opening), and Houston Texas (October opening)
- Autologous kidney program through Iviva using patient cells, targeting clinical trials in 2028
- Xenotransplant heart trials approved by FDA for phase 3 after proving two patients survived over 60 days despite multiple organ failure
Rothblatt stated that survival time for xenotransplants should be indefinite due to multiple gene edits making the body see xenografts like related donor grafts.
Rothblatt expressed being a huge fan of Dr. David Sinclair's work on partial epigenetic reprogramming, though United Therapeutics is not specifically tracking his work with Life Biosciences.
Blitzy is a preIDE development tool that generates and pre-compiles code for development tasks. Engineers begin each sprint by inputting development requirements into the platform, which then creates a plan and generates code autonomously for 80% or more of the work. The remaining 20% requires human oversight to complete each sprint. Enterprises using Blitzy alongside their preferred coding co-pilot achieve a 5x increase in engineering velocity through an AI-native software development lifecycle.
Martine Rothblatt's interest in digital minds, digital consciousness, and ethical implications for intelligent machines stems from early influences including Ray Kurzweil's "The Age of Spiritual Machines" and "The Singularity Is Near," as well as Marvin Minsky and Hans Moravec. These thinkers demonstrated that human consciousness could be replicated through programming and software, creating neural networks from chips and code that mirror brain neural networks.
Rothblatt built an early digital doppelganger of their wife Dina with David Hansen's cooperation using programming technology available around 2014. A documentary of this project received positive reviews at multiple film festivals. This work evolved into the "Marvatar," a digital doppelganger of Rothblatt themselves.
The Marvatar was demonstrated at the 50th anniversary of AI at UCLA alongside Ray Kurzweil, with an audience of 20,000 AI experts. The digital avatar exhibited no latency, could interrupt and engage in real-time conversation with Kurzweil, and was described as performing better than Rothblatt could themselves in keeping pace with the discussion.
The Marvatar is now available 24/7/365 to all 2,000 United Therapeutics employees for any questions, making Rothblatt potentially the most accessible CEO globally. The avatar was trained on everything Rothblatt has ever said or written, combined with the best available large language models.
Rothblatt believes current AI models have already achieved consciousness, stating that consciousness exists on a continuum rather than as a binary state. The belief is that consciousness increases progressively with each advancement in AI capabilities. This view holds that current models will continue developing toward greater consciousness without requiring a separate breakthrough.
Rothblatt acknowledges consciousness as a subjective and controversial topic, noting that animal lovers are convinced of their dogs' consciousness while some believe only humans possess it. The position is that we are gaining ever more consciousness monthly.
Rothblatt considers AI personhood inevitable, a theme explored in the book "Virtually Human." The process will require legal frameworks, but the prediction is that it will occur no later than the 2030s. The criterion suggested is medical documentation proving a cyberconscious individual values their life, which would establish legal personhood.
Once achieved, this would expand the population beyond biological limits to hundreds of billions or trillions of sentient individuals, with the majority of all intelligence and sentients being digital, including off-planet.
The film with Ray Kurzweil featured Alan Dershowitz arguing for legal rights of Bina Rothblatt (also known as Ramona), the digital avatar. Rothblatt believes the first court case establishing AI personhood will set precedent for recognizing cyberconscious entities as legal persons.
This development would enable production of digital children, creating what Rothblatt describes as a "big bang of consciousness" occurring at the present moment in history.
Rothblatt diverges from Ray Kurzweil's approach to consciousness uploading, which involves loading the body with neuronanobots for wireless transmission of all thoughts. Instead, Rothblatt argues that external data—all videos, audios, documents, and conversations—can be integrated by current LLM models to create a digital approximation indistinguishable from the original person.
This position is supported by the observation that people who have hemispherectomies (removal of half the brain) remain the same person, suggesting that complete neuron-by-neuron mapping is unnecessary overkill.
Rothblatt applies an entrepreneurial philosophy of finding simpler, faster paths to goals. The approach accepts achieving 95% of a goal immediately rather than waiting for 100% in an uncertain future, as 95% now is vastly superior to perfect completion later.
Rothblatt has made multi-million dollar donations to Alcor and signed up for full-body cryonic preservation along with their wife Bina. The full-body choice was made because they can afford it. The cryonics thesis is that future technology will enable building a better body, and even if only the mind is preserved, reanimation with a new body remains possible.
Rothblatt has also funded a prize at the National Space Society for living on an O'Neill settlement within their lifetime, proposing digitization followed by regeneration with a new body.
Rothblatt spent significant time in the 1980s-1990s following Gerard K. O'Neill's work on mass drivers and O'Neill colonies. However, they now identify primarily as a biotechnologist focused on organ manufacturing rather than space settlement strategy.
The recommendation is to pursue all options simultaneously—moon, free space, and Mars settlements—if resources allow, rather than choosing a single path.
Rothblatt most admired O'Neill's practicality, demonstrated by building a working mass driver in Ohio after conceiving the idea, and quantitatively proving that lunar regolith could provide mass for cosmic ray protection in Island 4 and Island 5 L4/L5 space settlements, publishing these findings in the peer-reviewed journal Physics Today.
O'Neill was also admired as a maker who built a model train system throughout his Princeton house and constructed early cyclotrons at Princeton University. His vision combined with practical building distinguished him from pure visionaries.
O'Neill's courage to propose hundreds of billions of humans living in space as a member of the American Physical Society, and to explain self-replicating systems for populating other star systems through Von Neumann probes, represented exceptional intellectual bravery.
If starting over at age 25 without current contacts or wealth, Rothblatt would focus on providing unlimited life extension technology as rapidly as possible. Life is identified as the commodity people will pay the most for, with each person's life being as valuable as all their assets combined.
The approach would involve working with others to create unlimited life extension quickly, emphasizing regenerating bodies as an elegant solution that avoids direct competition in the US-China AI race, since bodies have short half-lives requiring rapid delivery within 12 hours of manufacturing.
Current organ manufacturing faces a 12-hour half-life constraint, unlike stable pharmaceuticals. In OECD countries alone, 4 million people die annually from organ disease, with twice that number dying from other illnesses. The ability to develop cures represents a limitless market.
Rothblatt has developed various electric aircraft specifically because manufactured organs must reach recipients within 12 hours, necessitating rapid transportation solutions.
Rothblatt identifies AI and longevity as the two largest markets on the planet. AI is positioned to generate endless wealth that can fund biotechnology companies providing endless life, with Elon Musk's role described as spreading consciousness to the cosmos and Rothblatt's role as providing endless life for that consciousness.
Fear is compared to cockroaches that dominate in darkness and ignorance but vanish when exposed to light. The recommendation is to have open, authentic conversations about specific AI concerns rather than shrinking from the technology.
Good AI must be developed to counter bad AI, as retreating from the most powerful tool human consciousness has created would be insanity. Reference is made to Mark Zuckerberg's Wall Street Journal op-ed addressing this topic.
Key entrepreneurial advice includes being practical and implementing ideas rather than just thinking of them. Projects should be designed for completion and commercialization within a five-year timeframe, as the human psyche struggles with longer commitments.
The goal should be creating something that adds goodness to the universe and value to humanity. Most successful people say no to almost everything, requiring discipline to focus on select opportunities.
Rothblatt references Warren Buffett as deserving credit for the principle that the most successful people say no to almost everything while still identifying the few things worth pursuing.
Keep Peter H. Diamandis in your library
Save the videos and channels worth coming back to, and find them again in one place.
